Skip to content
Open access · OA via OpenAlex

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease

Ivana Devic, Hye‐Jin Hwang, John Scott Edgar, Kenneth T. Izutsu, Richard B. Presland, Catherine Pan, David R. Goodlett, Yu Wang, Jeff Armaly, Vítor Tumas, Cyrus P. Zabetian, James B. Leverenz, Min Yan Shi, Jing Zhang

Brain · 2011 · ▲ 222 citations

Abstract

Sir, Parkinson's disease is a neurodegenerative disorder belonging to a group of heterogeneous diseases characterized by a progressive and relatively selective loss of anatomically or physiologically related neuronal systems (Lang and Lozano, 1998; Silvers and Som, 1998). The identification of Parkinson's disease specific biomarkers, particularly at early stages, is critical for Parkinson's disease diagnosis, monitoring disease progression and patient management as well as the development of therapeutic interventions. Thus far, the proteins α-synuclein (α-Syn) and DJ-1 have been tested rigorously in Parkinson's disease. In our recent study published in Brain (Hong et al. , 2010), where a large cohort of patients with Parkinson's disease and controls were included, we provided evidence that α-Syn, along with DJ-1, decreases in Parkinson's disease CSF, providing high sensitivity and specificity for Parkinson's disease diagnosis. However, even though CSF is close to the main site of pathology in Parkinson's disease and other neurodegenerative disorders in the CNS, it cannot be readily obtained in most clinical settings (Shi et al. , 2010). To address this issue, several groups have examined serum/plasma concentrations of α-Syn and DJ-1 as potential biomarkers of Parkinson's disease. Unfortunately, a major drawback in assessing serum/plasma α-Syn and DJ-1 levels is the fact that >95% of total blood α-Syn and DJ-1 are derived from red blood cells. After controlling for several major variables, we concluded in a recent investigation that, unlike CSF, these two markers in plasma are unable to differentiate patients with Parkinson's disease from controls (Shi et al. , 2010). Of note, blood contamination of human CSF is also a major problem when assessing levels of α-Syn and DJ-1 in CSF (Hong et al. , 2010; Shi et al. , 2010). In an effort to look for other potential sources of clinically accessible samples for Parkinson's disease diagnosis …

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/brain/awr015
Canonical
link ↗
Fetched
2026-10-21 MST

Cite this

APA
Devic, I., Hwang, H., Edgar, J.S., Izutsu, K.T., Presland, R.B., Pan, C., Goodlett, D.R., Wang, Y., Armaly, J., Tumas, V., Zabetian, C.P., Leverenz, J.B., Shi, M.Y., &amp; Zhang, J. (2011). Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. <em>Brain</em>. https://doi.org/10.1093/brain/awr015
Vancouver
Devic I, Hwang H, Edgar JS, Izutsu KT, Presland RB, Pan C, et al. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain. 2011. doi:10.1093/brain/awr015.
BibTeX
@article{ivana2011Saliva, title = {Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease}, author = {Ivana Devic and Hye‐Jin Hwang and John Scott Edgar and Kenneth T. Izutsu and Richard B. Presland and Catherine Pan and David R. Goodlett and Yu Wang and Jeff Armaly and Vítor Tumas and Cyrus P. Zabetian and James B. Leverenz and Min Yan Shi and Jing Zhang}, journal = {Brain}, year = {2011}, doi = {10.1093/brain/awr015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings